Thienopyridine derivatives and use thereof as HSP90 modulators

Details for Australian Patent Application No. 2006220095 (hide)

Owner Merck Patent GmbH

Inventors Eggenweiler, Hans-Michael; Wolf, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006220095

PCT Pub. Number WO2006/092202

Priority 10 2005 009 440.6 02.03.05 DE

Filing date 10 February 2006

Wipo publication date 8 September 2006

Acceptance publication date 2 February 2012

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/092202 Priority application(s): WO2006/092202

2 February 2012 Application Accepted

  Published as AU-B-2006220095

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220096-Use of thiopeptolides for determining the activity of ADAMTS proteases

2006220071-Brake-disc, in particular for a vehicle